Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A seven-year review of the RCPAQAP dried bloodspot external quality assurance program.

Clinical chemistry and laboratory medicine·2026
Same author

Aggressive multifocal recurrent porocarcinoma of the face: a case report and review of the literature.

Journal of surgical case reports·2026
Same author

Response to letter to editor to "Procalcitonin assay variation in an Australasian external quality assurance program": A reappraisal.

Annals of clinical biochemistry·2026
Same author

Agreeing Language in Veterinary Endocrinology (ALIVE): Hypothyroidism, Hyperthyroidism, (Euglycaemic) Diabetic Ketosis/Ketoacidosis, and Diabetic Remission-A Modified Delphi-Method-Based System to Create Consensus Definitions.

Veterinary sciences·2026
Same author

Primary adrenal angiosarcoma: a rare case presentation.

Journal of surgical case reports·2025
Same author

Procalcitonin assay variation in an Australasian external quality assurance program.

Annals of clinical biochemistry·2025

Related Experiment Video

Updated: Aug 27, 2025

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.1K

Malignant inflammatory myofibroblastic tumor: a rare case presentation.

Megan Spafford1, Danley Lunn1, Peter Graham1

  • 1Department of General Surgery, University of Saskatchewan, Saskatoon, SK, Canada.

Journal of Surgical Case Reports
|September 23, 2022
PubMed
Summary

Malignant inflammatory myofibroblastic tumors (IMT) are rare, aggressive abdominal masses. Early suspicion and diagnosis are crucial for improving patient outcomes due to lack of established criteria.

Area of Science:

  • Oncology
  • Pathology

Background:

  • Malignant inflammatory myofibroblastic tumors (IMT) are rare and aggressive neoplasms.
  • Their presentation is variable, often mimicking other abdominal pathologies like gastrointestinal stromal tumors (GIST).

More Related Videos

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

1.7K
Isolation of Primary Myofibroblasts from Mouse and Human Colon Tissue
06:59

Isolation of Primary Myofibroblasts from Mouse and Human Colon Tissue

Published on: October 12, 2013

19.9K

Related Experiment Videos

Last Updated: Aug 27, 2025

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.1K
Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

1.7K
Isolation of Primary Myofibroblasts from Mouse and Human Colon Tissue
06:59

Isolation of Primary Myofibroblasts from Mouse and Human Colon Tissue

Published on: October 12, 2013

19.9K